September 21, 2017

University of Kansas honors Lindsley’s pharmacology research

Craig Lindsley, Ph.D., co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been honored by the University of Kansas with the 2018 Edward E. Smissman Lectureship for his outstanding contributions to the fields of medicinal chemistry and molecular pharmacology.

Craig Lindsley, Ph.D., co-director of the Vanderbilt Center for Neuroscience Drug Discovery, has been honored by the University of Kansas with the 2018 Edward E. Smissman Lectureship for his outstanding contributions to the fields of medicinal chemistry and molecular pharmacology.

Craig Lindsley, Ph.D.

Lindsley will deliver a series of lectures and receive the Smissman Medal at the university’s School of Pharmacy in Lawrence, Kansas, next fall. The lectureship is named for the distinguished scientist and former chair of Medicinal Chemistry at Kansas who died in 1974.

Previous honorees include Nobel laureates Sir Derek H.R. Barton, Ph.D., Julius Axelrod, Ph.D., and Barry Sharpless, Ph.D., and National Medal of Science winners Ronald Breslow, Ph.D., and Carl Djerassi, Ph.D.

“It is a real honor to be named the 22nd Smissman Memorial Lecturer,” Lindsley said. “Professor Smissman was a giant in the field of medicinal chemistry, and I am humbled to be among the list of those honored with this lecture.”

Lindsley is the William K. Warren Jr. Professor of Medicine and professor of Pharmacology and Chemistry. He has contributed to the discovery and development of drugs that can adjust the activity of receptors in the brain and could lead to new treatments for Parkinson’s disease, schizophrenia and Alzheimer’s disease.

Earlier this year he was awarded the 2017 Pharmacia-ASPET Award in Experimental Therapeutics from the American Society for Pharmacology and Experimental Therapeutics (ASPET) for the development of technology-enabled synthesis techniques for accelerating discovery of potential new drugs.